Robert Dunn Buys 200,000 Shares of DIAGNOS (CVE:ADK) Stock

Posted by on Aug 2nd, 2026

DIAGNOS Inc. (CVE:ADK – Get Free Report) Director Robert Dunn bought 200,000 shares of the firm’s stock in a transaction on Wednesday, July 29th. The shares were bought at an average price of C$0.30 per share, for a total transaction of C$60,000.00. Following the completion of the transaction, the director directly owned 2,117,778 shares in the company, valued at approximately C$635,333.40. This represents a 10.43% increase in their position.

DIAGNOS Stock Performance

CVE:ADK opened at C$0.28 on Friday. The firm’s fifty day simple moving average is C$0.24 and its 200-day simple moving average is C$0.26. The company has a quick ratio of 0.68, a current ratio of 1.49 and a debt-to-equity ratio of 204.05. The stock has a market cap of C$33.11 million, a PE ratio of -6.88 and a beta of -0.12. DIAGNOS Inc. has a fifty-two week low of C$0.17 and a fifty-two week high of C$0.41.

DIAGNOS Company Profile

(Get Free Report)

DIAGNOS Inc provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence.

Featured Articles

Receive News & Ratings for DIAGNOS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DIAGNOS and related companies with MarketBeat.com's FREE daily email newsletter.